MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/mus.26637

Медицинская библиотека · Muscle & nerve · 2019

Statin-induced myasthenia: A disproportionality analysis of the WHO's VigiBase pharmacovigilance database.

Gras-Champel Valerie, Batteux Benjamin, Masmoudi Kamel, Liabeuf Sophie

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Statins have been linked to myasthenia gravis (MG) in recent case reports. However, MG is not currently listed as an adverse drug reaction (ADR) in the summary of product characteristics.

METHODS

We performed case/noncase analyses in VigiBase® (the World Health Organization international database of suspected ADR) to identify a signal of MG (expressed as the reporting odds ratio [ROR] and its 95% confidence interval [CI]) for statins.

RESULTS

A total of 3967 reports mentioned MG. Of these, 169 were suspected to be statin-induced. A disproportionality signal was found for MG and statins use (ROR [95%CI] = 2.66 [2.28-3.10]).

CONCLUSIONS

The present disproportionality analysis revealed a possible drug safety signal linking MG and statins. This potential signal is weak, and is offset by the cardiovascular benefits of statins. Clinicians should be aware of this potential ADR, because it may require consideration of statin withdrawal or treatment of MG.

Для цитирования: Gras-Champel Valerie, Batteux Benjamin, Masmoudi Kamel, Liabeuf Sophie. Statin-induced myasthenia: A disproportionality analysis of the WHO's VigiBase pharmacovigilance database.. Muscle & nerve. 2019. DOI: 10.1002/mus.26637.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.